Blonder Tongue Laboratories, Inc.

    Blonder Tongue Laboratories, Inc.

    OOTC:BDRL
    0.02
    USD
    -0.01
    (-22.73%)
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    4.93
    4.48
    4.68
    3.24
    3.04
    2.84
    2.44
    2.07
    1.65
    1.3
    1.36
    0.94
    0.77
    0.81
    Basic EPS, GAAP
    -0.83
    -0.45
    -0.14
    -1.05
    -0.16
    -0.05
    -0.15
    -0.08
    -0.76
    0.01
    -0.22
    -0.15
    -0.09
    -0.08
    Free Cash Flow per Basic Share
    -0.64
    0.16
    0.17
    -0.19
    0.1
    -0.04
    0.06
    -0.69
    -0.33
    -0.1
    -0.11
    0.1
    0.07
    0.11
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.06
    -0.51
    -0.66
    -1.89
    -2.32
    -2.18
    -2.15
    -2.07
    -2.77
    -2.25
    -2.28
    -2.31
    -2.33
    -2.26
    Tangible Book Value per Share
    2.11
    1.85
    1.71
    0.72
    0.58
    0.67
    0.61
    0.6
    -0.02
    0.17
    -0.01
    -0.13
    -0.21
    -0.14
    Basic Weighted Avg Shares
    6
    6
    6
    6
    7
    8
    9
    10
    10
    12
    13
    14
    14
    14
    Sales/Revenue/Turnover
    31
    28
    29
    21
    23
    23
    22
    20
    16
    16
    18
    13
    11
    12
    Operating Margin (%)
    -8.14
    -9.13
    -2.16
    -30.56
    -2.98
    1.99
    -3.93
    -38.51
    -43.43
    -18.79
    -11.76
    -9.52
    -6.11
    -5.66
    Depreciation Expense
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    Net Income, GAAP
    -5
    -3
    -1
    -7
    -1
    - -
    -1
    -1
    -7
    - -
    -3
    -2
    -1
    -1
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    15.15
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -16.83
    -10.13
    -3.1
    -32.33
    -5.31
    -1.65
    -6.17
    -3.74
    -45.63
    0.53
    -16.12
    -16.02
    -11.18
    -10.49
    Working Capital
    10
    9
    9
    - -
    3
    5
    2
    4
    1
    2
    - -
    -2
    -3
    -2
    LT Debt
    4
    4
    4
    - -
    4
    4
    - -
    3
    4
    3
    6
    5
    5
    5
    Total Equity
    17
    15
    14
    7
    7
    7
    7
    7
    1
    3
    1
    -1
    -2
    -1
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -29.11
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -2.51
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    4
    4
    3
    LT Borrowings
    2
    2
    2
    LT Finance Leases
    3
    3
    3
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    14
    14
    14
    Market Capitalization
    1
    1
    1

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    5
    5
    5
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    2
    2
    2
    Inventories
    3
    3
    3
    Total Current Liabilities
    6
    7
    6
    Payables & Accruals
    2
    3
    3
    ST Debt
    4
    4
    3
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    5.14%
    19.24%
    229.96%
    Free Cash Flow
    -238.22%
    -62.47%
    -23.4%
    Net Income, GAAP
    -213.4%
    -567.72%
    -41.05%
    Sales/Revenue/Turnover
    -8.14%
    -9.77%
    -15.5%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    4
    3
    3
    3
    13
    2024
    3
    3
    - -
    - -
    11
    2025
    3
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.04
    -0.05
    -0.02
    - -
    -0.15
    2024
    -0.02
    -0.01
    - -
    - -
    -0.09
    2025
    -0.02
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Blonder Tongue Expands NTSC Line with Launch of CV NTSC32 IP Digital-to-Analog Synthesizer

    • NAGRAVISION and Blonder Tongue Partner to Secure Next-Generation Content Distribution for Hospitality Venues Across North America

    • Blonder Tongue Announces Extensive 20 Year Service Offering for NXG Video Delivery System

    • Blonder Tongue Laboratories, Inc. (BDRL) Q3 2022 Earnings Call Transcript

    • Blonder Tongue Schedules Conference Call to Discuss Third Quarter 2022 Earnings Results

    • Blonder Tongue Laboratories, Inc. (BDRL) CEO Ted Grauch on Q2 2022 Results - Earnings Call Transcript